Month: January 2022

SAN FRANCISCO, Jan. 24, 2022 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading destination for learning and teaching online, today announced it will release its financial results for its fourth quarter ended December 31, 2021, after market close on February 9, 2022. Udemy will host a conference call and earnings webcast beginning at 5:00 p.m. EST / 2:00 p.m. PST on the same day to discuss the company’s financial results. Interested parties may access the conference call by registering here. The conference call will also be webcast live on the Udemy Investor Relations website at https://investors.udemy.com/. Shortly after the conclusion of the live earnings call, an archived replay of the webcast will be available on the Udemy Investor Relations website at https://investors.udemy.com/. About UdemyUdemy’s (Nasdaq: UDMY) mission...

Interim data presented in poster reflects median overall survival of 12.0 months, not yet final, and an objective response rate of 48%, both greater than historical rates reported for standard of careMINNEAPOLIS, Jan. 24, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced the presentation of interim clinical data from its Phase 1b combination therapy study of SBP-101, a proprietary polyamine analogue, with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma (PDA), at the American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Meeting that took place January 20-22, 2022. Jennifer K. Simpson, PhD, MSN, CRNP President & Chief...

Tampa, FL, Jan. 24, 2022 (GLOBE NEWSWIRE) — RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, is proud to announce that we have partnered with Preya Co and MCAP Mediawire to maximize our communication and exposure with current and potential shareholders in conjunction with refining and broadening our overall messaging and outreach. This is in anticipation and because of the overwhelming response from the public and medical field from our pending DeltaWave 510k approval and market release. “We feel we owe it to our current and future investors to have partnered with a gold star firm to assist us with our investor relations moving forward. Maintaining an open line of communication with our shareholders and providing...

New York, NY, and Tel Aviv, ISRAEL, Jan. 24, 2022 (GLOBE NEWSWIRE) — §  Clinical Data Will be Released Thursday, January 27th, 2022 via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL protease theragnostic joint venture partner NLC Pharma Ltd., today announced a data lock for the interim data analysis for the Company’s Tollovir™ Phase 2 Clinical Trial for the treatment of hospitalized (severe/critical) COVID-19 patients. The Company will release the results on Thursday, January 27th, 2022. “We are very excited to see the first controlled clinical trial data for Tollovir,” said Dr. Dorit Arad, Founder & Chief Scientific Officer of NLC Pharma, Todos Medical’s 3CL protease biology theragnostics joint venture partner. “We are also...

Not for distribution to United States newswire services or for dissemination in the United States Funds to be Used to Restart Operations at Bradshaw Gold Deposit TORONTO, Jan. 24, 2022 (GLOBE NEWSWIRE) — Gowest Gold Ltd. (“Gowest” or the “Corporation”) (TSX VENTURE: GWA) announced today that Greenwater Investment Hong Kong Limited (“Greenwater”) has agreed to purchase from Gowest, on a private placement basis, pursuant to a subscription agreement between the parties dated January 24, 2022:promissory notes in an aggregate principal amount of $7,500,000 (the “Promissory Notes”), for an aggregate purchase price of $7,500,000 (the “Promissory Note Offering”), which shall be convertible, subject to the receipt of requisite shareholder approval, into Units (as defined below); and,subject to the receipt of requisite shareholder approval,...

H&R Block shares the top considerations for the upcoming tax season Company highlights the importance of filing to reconcile past federal payments KANSAS CITY, Mo., Jan. 24, 2022 (GLOBE NEWSWIRE) — As record inflation continues to pressure Americans’ paychecks, H&R Block (NYSE: HRB) is here to help people get their biggest refund possible in a year in which tax law changes require reconciling past federal payments, such as stimulus checks and the advance child tax credit. “There are a variety of changes people will notice when filing taxes this year, including expansions in the tax code designed to help the U.S. economy and families recover from the pandemic,” said Karen Orosco, president of global consumer tax and service delivery of H&R Block. “There’s more money for more people – from new incentives to help families,...

MedSafe is a proven solution for cost-effective and efficient management of unused medications in Long-Term Care Communities HOUSTON, Jan. 24, 2022 (GLOBE NEWSWIRE) — Sharps Compliance Corp. (Nasdaq: SMED), a nationwide provider of medical waste and unused medication management solutions, announces its partnership with PharMerica Corporation, a nationwide leader in long-term care (LTC) pharmacy services, to make the Sharps MedSafe available to the LTC facilities in PharMerica’s network. PharMerica currently works with more than 2,500 facilities across the U.S. MedSafe is a proprietary and leading DEA-compliant ultimate user medication management solution, ideal for use in LTC settings. In addition to unused medication management, the MedSafe is designed to reduce cost to LTC facilities through effective and efficient collection,...

SACRAMENTO, Calif., Jan. 24, 2022 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer of specialty alcohols and essential ingredients, updated its full-year 2021 gross profit guidance. The company now expects full-year 2021 gross profit to exceed $60 million. This is an increase from prior guidance of a minimum of $40 million dollars, provided on November 9, 2021, in conjunction with reporting the third quarter 2021 results. Michael Kandris, Alto Ingredients’ president and CEO, stated, “Due to strong fourth quarter fuel ethanol margins combined with our operational improvements, we have increased our full-year 2021 gross profit guidance by 50% to over $60 million.” Management expects to report fourth quarter and year-end 2021 financial results in the first half of March 2022. About Alto Ingredients, Inc. Alto...